These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease. Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802 [TBL] [Abstract][Full Text] [Related]
8. [Remnant like particles as a risk factor for coronary artery disease]. Ikewaki K; Mochizuki S Nihon Rinsho; 2002 May; 60(5):1032-7. PubMed ID: 12029982 [TBL] [Abstract][Full Text] [Related]
9. High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis. Nakamura T; Obata JE; Takano H; Kawabata K; Sano K; Kobayashi T; Fujioka D; Saito Y; Yano T; Kugiyama K Atherosclerosis; 2009 Jan; 202(1):234-40. PubMed ID: 18456269 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of remnant lipoprotein-cholesterol measurements: the immune adsorption method (RLP-C) and the direct assay with detergent (RemL-C)]. Hihara M; Sato I; Hayashi F; Sugiyama D; Kawano S; Fujioka Y; Ishikawa Y; Kumagai S Rinsho Byori; 2009 Jan; 57(1):24-30. PubMed ID: 19227187 [TBL] [Abstract][Full Text] [Related]
11. [Method for remnant lipoproteins--quantitative analysis of serum remnant-like particle cholesterol (RLP-C)]. Nambu S Nihon Rinsho; 1999 Dec; 57(12):2740-4. PubMed ID: 10638206 [TBL] [Abstract][Full Text] [Related]
12. [Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in a postprandial as well as fasting state]. Akuzawa K; Nakano T; Sekiguchi I; Shimoyama M; Adachi M; Tange S; Tanaka A; Tada N; Nakajima K Rinsho Byori; 1995 Nov; 43(11):1159-67. PubMed ID: 8551681 [TBL] [Abstract][Full Text] [Related]
14. [Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis]. Funada J; Sekiya M; Otani T; Watanabe K; Akutsu H J Cardiol; 2001 May; 37(5):267-76. PubMed ID: 11392896 [TBL] [Abstract][Full Text] [Related]
15. Remnant-like lipoproteins, hormone therapy, and angiographic and clinical outcomes: the Women's Angiographic Vitamin & Estrogen Trial. Bittner V; Tripputi M; Hsia J; Gupta H; Steffes M; Am Heart J; 2004 Aug; 148(2):293-9. PubMed ID: 15308999 [TBL] [Abstract][Full Text] [Related]
17. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of hypercholesterolemia in the elderly]. Alcântara P; Bicho M; Clara JG Rev Port Cardiol; 1992; 11(7-8):685-90. PubMed ID: 1389308 [TBL] [Abstract][Full Text] [Related]
19. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related]
20. Triglycerides and remnant particles as risk factors for coronary artery disease. Nakamura T; Kugiyama K Curr Atheroscler Rep; 2006 Mar; 8(2):107-10. PubMed ID: 16510044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]